Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. Jul 15, 2024; 16(7): 3241-3255
Published online Jul 15, 2024. doi: 10.4251/wjgo.v16.i7.3241
Published online Jul 15, 2024. doi: 10.4251/wjgo.v16.i7.3241
Figure 1 RNA binding motif 5 is lowly expressed in colorectal cancer tissues and cells.
A: The mRNA expression of RNA binding motif 5 (RBM5) in tumor tissues and normal tissues was analyzed via the Gene Expression Profiling Interactive Analysis; B: Relative mRNA expression of RBM5 in fetal human cell (FHC), HT29, HCT116, LOVO, SW480 and SW620 cells was detected by quantitative real time-polymerase chain reaction; C: Relative protein expression of RBM5 in FHC, HT29, HCT116, LOVO, SW480, and SW620 cells was detected by Western blot. RBM5: RNA binding motif 5. aP < 0.05, bP < 0.01, cP < 0.001.
- Citation: Wang CX, Liu F, Wang Y. RBM5 suppresses proliferation, metastasis and glycolysis of colorectal cancer cells via stabilizing phosphatase and tensin homolog mRNA. World J Gastrointest Oncol 2024; 16(7): 3241-3255
- URL: https://www.wjgnet.com/1948-5204/full/v16/i7/3241.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i7.3241